TY - JOUR T1 - Adjusting for treatment crossover in the METRIC metastatic melanoma (MM) trial for trametinib: Preliminary analysis. JO - Journal of Clinical Oncology PY - 2013/05/20 AU - Abrams KR AU - Latimer N AU - Amonkar M AU - Stapelkamp C AU - Casey M ED - DO - DOI: 10.1200/jco.2013.31.15_suppl.9040 PB - American Society of Clinical Oncology (ASCO) VL - 31 IS - 15_suppl SP - 9040 EP - 9040 Y2 - 2025/06/27 ER -